Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with acute coronary syndromes (ACS), ticagrelor appears to be more effective than clopidogrel in reducing the incidence of death from vascular…
NEW YORK (Reuters Health) – Over time, vaccine-induced rubella antibody levels decline and seronegativity rates rise, leaving children vulnerable to infection, public health officials report. “Because rubella is…
NEW YORK (Reuters Health) – A low-carbohydrate, Mediterranean-style diet is more effective than a conventional low-fat, calorie restricted diet for patients with type II diabetes, according to results…
NEW YORK (Reuters Health) – Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed type 2 diabetes,…
NEW YORK (Reuters Health) – Hormone replacement therapy (HRT) with estrogen/progestin reduces the risk of colorectal cancer, but Israeli researchers have found that aspirin use and an active…
NEW YORK (Reuters Health) – For patients at high risk for coronary disease who do not sufficiently adjust their cholesterol levels with a moderate dose of a statin,…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
NEW YORK (Reuters Health) – Instead of requiring surgery, a diagnosis of endometriosis can now be made with a biopsy, according two studies published this month in the…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
NEW YORK (Reuters Health) – Women treated for grade 1 breast cancer have a low risk of locoregional recurrence and contralateral breast cancer, results of a study indicate.…
